Skip to main content

Want a detailed portfolio tracker?

Revolution Medicines (RVMD) P/E (2020 - 2026)

Revolution Medicines (RVMD) P/E from Mar 31, 2020 to Jun 2, 2026. The TTM Revolution Medicines (RVMD) P/E is -21.45. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Revolution Medicines (RVMD)

YearP/EChange
2026-21.45+59.77%
2025-13.43+7.00%
2024-12.55+38.12%
2023-9.08+19.92%
2022-7.58-23.62%
2021-9.92-57.01%
2020-23.07N/A

Comparison Revolution Medicines (RVMD) P/E with competitors

Revolution Medicines (RVMD) P/E is -21.45.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.10-100.48%
ENLVEnlivex Therapeutics Ltd0.15-100.70%
FGENFibroGen Inc0.24-101.12%
TRAWTraws Pharma Inc0.47-102.20%
FBIOFortress Biotech Inc0.71-103.29%
CHRSCoherus Biosciences Inc0.98-104.56%
ORMPOramed Pharmaceuticals Inc1.47-106.87%
AGENAgenus Inc2.05-109.55%
VIVSVivoSim Labs Inc2.54-111.82%
INVAInnoviva Inc3.19-114.86%
CRMDCorMedix Inc3.65-117.00%
ABEOAbeona Therapeutics Inc4.20-119.60%
VXRTVaxart Inc4.26-119.87%
CVACCureVac N.V.4.45-120.72%
SRPTSarepta Therapeutics Inc4.62-121.56%
GLPGGalapagos NV4.86-122.65%
RIGLRigel Pharmaceuticals4.92-122.93%
ZVRAZevra Therapeutics Inc4.97-123.19%
ABUSArbutus Biopharma Corp5.69-126.54%
CGENCompugen Ltd7.38-134.42%
AUPHAurinia Pharmaceuticals Inc9.25-143.13%
ACADAcadia Pharmaceuticals Inc9.59-144.70%
OMEROmeros Corporation9.88-146.07%
PLXProtalix BioTherapeutics Inc9.91-146.19%
SPROSpero Therapeutics Inc10.73-150.04%
ADMAAdma Biologics Inc11.33-152.82%
SVASinovac Biotech Ltd11.44-153.31%
TBPHTheravance Biopharma Inc11.78-154.90%
HRMYHarmony Biosciences Holdings Inc12.18-156.78%
TGTXTG Therapeutics Inc13.18-161.44%
INCYIncyte Corp13.38-162.38%
SABSSAB Biotherapeutics Inc14.06-165.53%
XOMAXOMA Corp14.95-169.67%
REGNRegeneron Pharmaceuticals Inc14.98-169.84%
PBYIPuma Biotechnology Inc15.05-170.16%
EXELExelixis Inc15.79-173.63%
NAGENiagen Bioscience Inc16.35-176.24%
CPRXCatalyst Pharmaceuticals Inc17.34-180.86%
MDXGMimedx Group Inc17.38-181.00%
ARGXArgen X SE23.07-207.56%
HALOHalozyme Therapeutics Inc23.20-208.16%
XOMAOXOMA Corp25.34-218.15%
VRTXVertex Pharmaceuticals Inc25.66-219.60%
XOMAPXOMA Corp25.67-219.67%
CTMXCytomX Therapeutics Inc25.70-219.80%
ASNDAscendis Pharma A/S26.35-222.86%
RPRXRoyalty Pharma plc - Class A27.50-228.18%
SLNOSoleno Therapeutics Inc29.02-235.26%
LGNDLigand Pharmaceuticals Inc - Class B30.19-240.72%
BMRNBiomarin Pharmaceutical Inc37.51-274.85%
APLSApellis Pharmaceuticals Inc39.02-281.91%
KRYSKrystal Biotech Inc39.70-285.06%
GMABGenmab40.20-287.42%
ONCBeiGene Ltd67.03-412.47%
TECHBio-Techne Corp68.59-419.78%
VCELVericel Corp80.63-475.88%
PHARPharming Group N.V.87.74-509.03%
ALNYAlnylam Pharmaceuticals Inc124.93-682.42%
TLXTelix Pharmaceuticals Ltd139.89-752.15%
CORTCorcept Therapeutics Inc158.39-838.39%